Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LifeMDLFMD -5.45%72 Debt-to-Equity is 0.41 as of Mar. 2026. GuruFocus rates LFMD with a GF Score™ of 72/100 and a GF Value™ of $5.81 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 557 Healthcare Providers & Services companies, LifeMD ranks worse than 50.09% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for LifeMD's Debt-to-Equity or its related term are showing as below:
LFMD'
s Debt-to-Equity Range Over the Past 10 Years
Min: -23.55 Med: -0.19 Max: 5.4
Current: 0.41
During the past 13 years, the highest Debt-to-Equity Ratio of LifeMD was 5.40. The lowest was -23.55. And the median was -0.19.
LFMD's Debt-to-Equity is ranked worse than 50.09% of 557
companies
in the Healthcare Providers & Services industry
Industry Median: 0.41
vs LFMD: 0.41
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
LifeMD Debt-to-Equity Related Terms
LifeMD Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for LifeMD's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, LifeMD's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LifeMD Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, LifeMD's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where LifeMD's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LifeMD (LFMD) has a Debt-to-Equity of 0.41 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on LifeMD and its competitors. According to the industry distribution chart, LifeMD ranks #279 out of 557 companies in the Healthcare Providers & Services industry, placing it in the top 50.1%.
Is LifeMD's Debt-to-Equity too high?
LifeMD's current Debt-to-Equity is 0.41. The Healthcare Providers & Services industry median Debt-to-Equity is 0.41. LifeMD's value of 0.41 is 0% at this industry median. Based on the distribution chart, LifeMD ranks #279 out of 557 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, LifeMD has a GF Score™ of 72/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does LifeMD's Debt-to-Equity compare to AMWL and SY?
According to the Healthcare Providers & Services industry distribution chart, LifeMD ranks #279 out of 557 companies for Debt-to-Equity. This places LifeMD in the lower half of its industry. The industry median Debt-to-Equity is 0.41. LifeMD's value of 0.41 is 0% at this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.41, based on 557 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LifeMD's current Debt-to-Equity of 0.41 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on LifeMD and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LifeMD's current Debt-to-Equity is 0.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeMD stock overvalued right now?
Based on GuruFocus' analysis, LifeMD (LFMD) is currently considered Possible Value Trap. The stock's GF Value™ is $5.81, compared to a current price of $3.64 — trading 37.3% below its estimated fair value. The current Debt-to-Equity is 0.41 and 0% at the Healthcare Providers & Services industry median of 0.41. LifeMD's overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For LifeMD (LFMD), the current Debt-to-Equity is 0.41 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LifeMD (LFMD) Overvalued in 2026?
Based on GuruFocus' analysis, LifeMD stock appears to be undervalued.
The current stock price of $3.64 is trading 37.3% below its estimated GF Value™ of $5.81.
GuruFocus considers LifeMD to be Possible Value Trap.
Key valuation signals for LFMD:
Debt-to-Equity: 0.41
GF Value™: $5.81 vs. price of $3.64 (37.3% below fair value)
Industry Position: 0% at the Healthcare Providers & Services median (#279 of 557)
No single metric tells the full story. See the LFMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.
72GF Score
Get the complete analysis for LFMD
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LFMD has been successfully added to your 
